Close Menu

Illumina: Kathryne Reeves

Aug 25, 2020

Illumina has announced that Kathryne Reeves will join the firm as chief marketing officer on Sept. 28, 2020, reporting to CEO Francis deSouza.

Reeves brings more than 25 years of marketing and management experience and comes to Illumina from Cardinal Health, where she was senior VP of enterprise marketing and general manager of the medical services global business unit. Prior to that, she held positions at Booz Allen Hamilton, AOL/TimeWarner, Nationwide Insurance, and Scotts Miracle-Gro.

Reeves holds an MBA from Harvard Business School.

More Like This

Sep 29, 2020

BioAffinity Technologies: Martin Tammemägi

BioAffinity Technologies announced Martin Tammemägi will become chairman of the company's scientific and medical advisory board. He was a co-investigator and remains active in the US Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial, the US National Lung Screening Trial, and the Pan-Canadian Early Detection of Lung Cancer Study. He is an active associate member of the US National Institutes of Health National Cancer Institute Cancer Intervention and Surveillance Modeling Network lung group and is the provincial scientific lead for Ontario Health - Cancer Care Ontario’s Lung Cancer Screening Pilot for People at High Risk.

Sep 24, 2020

GenMark Diagnostics: Brian Mitchell

GenMark Diagnostics said in a filing with the US Securities and Exchange Commission that Brian Mitchell, its senior vice president of operations, is no longer employed by the company.

Sep 22, 2020

Exact Sciences: Eli Casdin

In a filing with the US Securities and Exchange Comission, Exact Sciences said that board member Eli Casdin had submitted his resignation from the company's board of directors, effective Sept. 21. Casdin is the chief investment officer and founder of Casdin Capital, an investment firm focused on the life sciences and healthcare industry.

Sep 22, 2020

Inivata: Peter Collins

Inivata has appointed Peter Collins as the firm's chief business officer. Prior to Inivata, Collins most recently held senior leadership positions at Guardant Health. He has also served as chief business officer at Yourgene Health. Prior to Yourgene, Collins served as VP, head of diagnostics at GSK, as well as VP of pharma business development at Qiagen. He was also the founder and board member of Epemed. 

Sep 18, 2020

Quidel: Robert Bujarski

Quidel has appointed Robert Bujarski as chief operating officer effective Sept. 14. Bujarski had been Quidel's SVP of commercial operations in North America and general counsel since July 2019, SVP of business development from August 2009 through July 2019, and corporate secretary until February 2019.

Sep 17, 2020

iAssay: Edward Strong

Edward Strong has been named scientific director of iAssay, a firm developing an open platform that consolidates utilization of a range of point-of-care tests with a single cloud-connected, handheld reader. Strong, a geneticist, formerly cofounded and served as CEO of MedGenomics, and also served as interim CEO of LifeGenomix.

Sep 17, 2020

Biofidelity: Stephen Miller

Biofidelity has appointed Stephen Miller as chief commercial officer. Miller has held leadership positions at both public and private companies including Precipio, BG Medicine, Thermo Fisher Scientific, and Athena Diagnostics.

Sep 16, 2020

Magnolia Medical Technologies: Richard Ivey, Paul Goldenbaum

Magnolia Medical Technologies has appointed two former Becton Dickinson senior executives to its medical and scientific advisory board. They are Richard Ivey, retired worldwide vice president of research and development for Becton Dickinson's life sciences diagnostic systems business, and Paul Goldenbaum, retired director of research and development for BD's diagnostic instrument systems division.

With BD, Ivey led an R&D team of several hundred engineers and scientists focused on diagnostic technologies, including infectious disease diagnostic instrumentation, laboratory automation engineering, microbiology, molecular biology, immunochemistry, and cytology.

With BD, Goldenbaum was charged with improving and expanding the Bactec blood culture media product line for sepsis testing. In this role, he developed the blood culture media for all generations of the Bactec blood culture system including radiometric, resin media, non-radiometric, and the current fluorescent, non-invasive media.

Sep 16, 2020

Gravity Diagnostics: Mary Talbott

Gravity Diagnostics has hired Mary Talbott as chief legal secretary and secretary. Talbott has more than 25 years of experience in corporate and private practice and most recently was senior vice president, general counsel, and corporate secretary for Tennant Company. Before that, she was VP, assistant general counsel, and assistant corporate secretary for General Cable. Gravity Dx is a full-service CLIA laboratory based in Covington, Kentucky and provides testing services in infectious diseases, toxicology, and pharmacogenomics.

Sep 15, 2020

Alveo Technologies: Fran Soistman

Fran Soistman has joined the scientific board of Alveo Technologies. He has more than 40 years of experience in the healthcare and managed care sector, including as executive vice president for Aetna. As a member of Alveo's scientific advisory board, Soistman will help guide the firm's efforts to implement its infectious disease testing technologies. Alameda, California-based Alveo is developing its be.well platform, a point-of-care, at-home diagnostic tool.

Sep 15, 2020

NeoGenomics: Madhushree Ghosh

NeoGenomics announced that Madhushree Ghosh has joined the company as VP of alliances and companion diagnostics. She previously served as the senior director of strategic accounts and global strategic partnerships at Thermo Fisher Scientific. She has also served as VP of alliance management and VP of the research services business unit at Althea Dx, as well as in senior leadership positions at Qiagen and Enigma Diagnostics. Ghosh has expertise in next-generation sequencing, multiplex and real-time PCR, oncology, and infectious diseases.

Sep 14, 2020

Veracyte: Richard Kloos

Veracyte has promoted Richard Kloos to executive medical director, overseeing the company's global medical affairs in all clinical areas addressed by its genomic tests. Kloos previously served as senior medical director of endocrinology at Veracyte, which he joined in 2012. He was previously a professor of endocrinology and metabolism, and nuclear medicine at Ohio State University, and was attending physician at the OSU Comprehensive Care Center. He was also codirector of the OSU Thyroid Cancer Unit and served a four-year term as secretary and chief operating officer for the American Thyroid Association.

Sep 14, 2020

Thermo Fisher Scientific: Joseph Holmes, Peter Hornstra

Joseph Holmes has been elected as VP and chief accounting officer of Thermo Fisher Scientific, effective March 31, 2021. He will succeed Peter Hornstra, who will retire from the company March 31. Holmes is currently senior director of technical accounting at Thermo Fisher, a position he assumed when he joined the company in 2017. Previously, he was director of technical accounting and reporting at St. Jude Medical, which was acquired by Abbott Laboratories in 2017.

Sep 14, 2020

GenMark Diagnostics: Brian Mitchell

GenMark Diagnostics said in a filing with the US Securities and Exchange Commission that Brian Mitchell, its senior vice president of operations, is no longer employed by the company.

Sep 11, 2020

Invitae: Kimber Lockhart

Invitae has appointed Kimber Lockhart to its board of directors effective Sept. 10. Lockhart has been chief technology officer at technology-enabled primary care organization One Medical since 2015. From 2009 to 2014, she held various engineering leadership positions at Box, an online file sharing service. Lockhart joined Box in 2009, when it acquired Increo Solutions, a document rendering and collaboration technlogy firm she cofounded and led as CEO.